Gemcitabine, cisplatin, prednisone, and thalidomide for relapse and refractory peripheral T-cell lymphoma: a retrospective study from China

BACKGROUND: Peripheral T-cell lymphoma (PTCL) is often prone to relapse and progression even after formal first-line treatment, and there is no standard regimen for second-line treatment. What is more, the activity of thalidomide against this type of lymphoma is unknown. PURPOSE: The objective of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiangli, Shang, YuFeng, Li, Ling, Zhang, Xudong, Li, Zhaoming, Zhang, Mingzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749983/
https://www.ncbi.nlm.nih.gov/pubmed/31571985
http://dx.doi.org/10.2147/CMAR.S215585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749983/
https://www.ncbi.nlm.nih.gov/pubmed/31571985
http://dx.doi.org/10.2147/CMAR.S215585

Ejemplares similares